No Photo Available

Last Update

2017-03-02T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Gary Sachs?

Dr. Gary S. Sachs

Founding Director, Bipolar Clinic and Research Program

Massachusetts General Hospital

HQ Phone: (617) 726-2000

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Massachusetts General Hospital

55 Fruit Street

Boston, Massachusetts 02114

United States

Company Description

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $800 m ... more

Find other employees at this company (12,167)

Background Information

Employment History

Therapeutic Area Leader

Bracket

Affiliations

Board Member
The CME Institute

Board Member
Depression and Bipolar Support Alliance

Board Member
Convio Inc

Advisory Board Member
The World Association of Medical Editors

Board Member
Physicians Postgraduate Press Inc

Founder
Collaborative Care Initiative, LLC

Associate Professor of Psychiatry
Massachusetts General Hospital

Founder
Concordant Rater Systems

Scientific Advisory Board
National Alliance on Mental Illness

Fellow
American Psychiatric Association

Member, Review Board
Journal of Clinical Psychiatry

Member, Review Board
New England Journal of Medicine

Member, Review Board
American Journal of Psychiatry

Board Member
Medscape LLC

Advisor Or Consultant
Abbott Laboratories company

Advisor Or Consultant
Eli Lilly and Company

Advisor Or Consultant
Wyeth

Advisor Or Consultant
AstraZeneca PLC

Advisor Or Consultant
Pfizer Inc

Advisor Or Consultant
GlaxoSmithKline plc

Education

University of Maryland Medical School

University of Pennsylvania

M.D.

Harvard Medical School

MA

MD

Harvard University

medical degree

University of Maryland School of Medicine

Web References (103 Total References)


BCP EDITORIAL BOARD AND SECTION EDITORS

www.psikofarmakoloji.org [cached]

Gary Sachs, MD, PhD Massachusetts General Hospital, Boston, USA


Düşünen Adam : Psikiyatri ve Nörolojik Bilimler Dergisi

www.dusunenadamdergisi.org [cached]

Gary S. Sachs, Prof., M.D. Department of Psychiatry, Massachusetts General Hospital, Boston,MA, USA


The Bipolarity Index Interview | PsychEducation

psycheducation.org [cached]

This is an important interview with Dr. Gary Sachs, head of the Harvard-associated Mood Disorders Clinic.

...
To find out, Elizabeth Saenger, PhD, Program Director of Medscape Psychiatry & Mental Health, interviewed Gary Sachs, MD, Director of the Bipolar Mood Program in the Clinical Psychopharmacology Unit, Director of the Harvard Bipolar Research Program, and Assistant Professor of Psychiatry at Massachusetts General Hospital in Boston, Massachusetts.
...
Dr. Sachs is also principal investigator for the National Institute of Mental Health study on Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Medscape: How do you evaluate patients for bipolar disorder?
Dr. Sachs: We certainly use the usual approach of taking a good history of the patient, but one thing that we do differently is approach the diagnostic issue not as a categorical yes-no sort of question, but more as a continuum question, so the issue becomes how much and in what ways is a patient bipolar.[1] What we do is concentrate on how the patient is now. His most extreme episode of mood elevation is our next focal point, and then we'll move systemically through family history, mental status, sexual history, childhood psychiatric illness, all the usual parts.
...
Dr. Sachs: Yes, and we're not looking to replace the Diagnostic and Statistical Manual with it. What we're trying to do is answer the patient's biggest question, "How likely is it that I have this disorder? And it isn't that we're infallible, either; it's just that we are able to approach it more as a continuous issue, rather than as a black-and-white, yes-no.
Medscape: Do you think that would then decrease the rate of misdiagnosis, which I understand is extremely high with bipolar disorder?
Dr. Sachs: Yes, that's kind of our goal, butit's more the issue of making it clearer to the patients what the diagnosis rests on.
...
Dr. Sachs: Yes.
...
Dr. Sachs: What we've found is that most people who have had 2 or 3 episodes of bipolar I will almost always score over 70, so scores over 70 make us pretty confident this is a bipolar I. And, obviously, if somebody is having a first episode and does not have any response to treatment, and doesn't have a course of illness, we can't have a score that's over 60.
...
Dr. Sachs: That probably isn't the question to ask me, because I'm not a child psychiatrist. But, generally, you see much more dysphoria mixed in. You don't see the distinct episodes, and so there are aspects of bipolar disorder in children that are very controversial, just because they lack those classic features.
Medscape: And is it also true of adolescents, where there's more dysphoria and the episodes are less distinct?
Dr. Sachs: I think by the time you get to adolescence, it's a lot easier for you to distinguish bipolar disorder from other psychiatric problems.
...
Dr. Sachs: What you're talking about here are 2 different issues.
...
Dr. Sachs: Yes, back when the Mood Disorder Questionnaire was being validated, Spitzer and William's group also conducted these interviews and they sort of established that 70 is a reasonable cutoff score, given the sensitivity and specificity issues.[2]
...
Dr. Sachs: Yes.
...
Dr. Sachs: Well, part of it really does use the pieces from motivational interviewing to perhaps get there, and we really try to be good negotiators, not in the sense of getting people to adopt our positions, but to work to establish external criteria to judge these measurements, so we can have an iterative approach to treatment.
...
Dr. Sachs: We really do.
...
Dr. Sachs: Well, the patients initially are given a shot at doing it themselves.
...
Disclosure: Gary Sachs, MD, has disclosed that he owns stock, stock options, or bonds in Concordant Rater Systems, LLC, and has received grants for educational activities from GlaxoSmithKline, AstraZeneca, Wyeth, Eli Lilly, Sanofi, and Abbott Laboratories. Dr. Sachs has also disclosed the he served as advisor or consultant for GlaxoSmithKline, Pfizer, AstraZeneca, Wyeth, Eli Lilly, Sanofi, and Abbott Laboratories.


Editorial Advisory Board : Innovations in Clinical Neuroscience

innovationscns.com [cached]

Gary S. Sachs, MD Associate Professor of Psychiatry, Harvard Medical School; Director, Bipolar Clinic and Research Program, Massachusetts General Hospital, Boston, Massachusetts


Video Files

www.bipolarworld.net [cached]

Collaborative Care: Patient, Family and Clinician Working Together to Improve Treatment and Quality of Life - Dr. Gary Sachs, Director, Bipolar Research Programs at Massachusetts General Hospital

Similar Profiles

Other People with this Name

Other people with the name Sachs

Susan Sachs
Cook & Company

Justin Sachs
Schneider

Jodi Sachs
Sanofi companies

Amy Sachs
The Tom James Company

Amanda Sachs
AssetMark Investment Services , Inc.

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory